Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 42
Selected: 0
NCT IDTitle
NCT02746068A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
NCT04634669Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)
NCT04039022Open-Label Safety Study of AXS-05 in Subjects With Depression
NCT06736509An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study
NCT04788953Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder
NCT06223880A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
NCT03896009Maximizing Outcomes in Treating Acute Migraine
NCT06413420SUNOSI® (Solriamfetol) Pregnancy Registry
NCT04789174Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study
NCT06170970Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
NCT03595579Assessing Symptomatic Clinical Episodes in Depression
NCT04163185Initiating Early Control of Migraine Pain and Associated Symptoms
NCT03881852Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)
NCT04068051Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)
NCT03226522Addressing Dementia Via Agitation-Centered Evaluation
NCT06360419Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol
NCT04947553A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation
NCT07398417Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
NCT06878976A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder
NCT04019704A Trial of AXS-05 in Patients With Major Depressive Disorder
NCT06568367Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
NCT04797715Assessing Clinical Outcomes in Alzheimer's Disease Agitation
NCT07773883An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
NCT02504008CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
NCT02741791A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder
NCT05550207Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)
NCT04608396Mechanistic Evaluation of Response in TRD (MERIT)
NCT07717892A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD
NCT04971291An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients
NCT05557409A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
NCT05008341Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration
NCT07637162Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia
NCT05113745A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)
NCT07717879A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD
NCT05059223A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy
NCT03471767AXS-05 Phase II Trial on Smoking Behavior
NCT07766655A Study to Evaluate the Efficacy and Safety of AXS-05 for Smoking Cessation in Adults
NCT07523048Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorder
NCT07484217Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
NCT05838430Solriamfetol and CBT-I in Patients With Insomnia Disorder
NCT06413433Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
NCT05972044A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)